Efficacy and cost of atypical antipsychotics in treatment and management of dementia

THONGCHUNDEE, Oranuch, GUMBER, Anil, KHATAB, Khaled and GUMBER, Leher (2015). Efficacy and cost of atypical antipsychotics in treatment and management of dementia. SM Journal of Neurological Disorders and Stroke, 1 (1).

	PDF Khatab 11582.pdf Restricted to Repository staff only Download (229kB) | Contact the author
Preview	PDF Gumber - fulltext_smjnds-v1-10029 (updated).pdf - Published Version Creative Commons Attribution. Download (1MB) | Preview

Abstract

There is a significant lack of pharmacoeconomic research on using atypical antipsychotics for the treatment of dementia. Further comprehensive research should be carried out into this field. We have found a good number of studies exploring the effectiveness and cost-effectiveness of atypical antipsychotics for schizophrenia using a decision-analytical model. However, there were only a couple of studies which have focused on the use of AAs for dementia and that too with several limitations. Therefore, it is pertinent to undertake further systematic and comprehensive research on the safety and efficacy of atypical antipsychotics for the management of BPSD. This is essential in improving clinical practice and suggesting better pathways for dementia treatment as well as in mitigating the adverse impacts on the quality of life of patients and their caregivers.

Item Type:	Article
Research Institute, Centre or Group - Does NOT include content added after October 2018:	Centre for Health and Social Care Research
Depositing User:	Khaled Khatab
Date Deposited:	23 Feb 2016 15:51
Last Modified:	18 Mar 2021 02:02
URI:	https://shura.shu.ac.uk/id/eprint/11582

Actions (login required)

View Item

Downloads

Publication Metrics